![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current AGRX market cap is 4.13M. The company's latest EPS is USD -2.1098 and P/E is -0.28.
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 4M | 3.81M | 5.5M | 6.66M | 3.61M |
Operating Income | -6.88M | -6.71M | -5.13M | -4M | -4.05M |
Net Income | 18.24M | -5.39M | -3.81M | -798k | -4.47M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 749k | 4.1M | 10.88M | 19.59M |
Operating Income | -18.86M | -49.05M | -71.01M | -41.43M | -19.88M |
Net Income | -18.61M | -51.85M | -74.89M | -25.41M | -14.47M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 14.24M | 13.7M | 12.57M | 10.89M | 10.26M |
Total Liabilities | 19.79M | 23.13M | 24.69M | 23.3M | 26.57M |
Total Equity | -5.55M | -9.43M | -12.12M | -12.41M | -16.32M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 49.54M | 73.06M | 39.33M | 14.24M | 10.26M |
Total Liabilities | 3.8M | 23.73M | 30.06M | 19.79M | 26.57M |
Total Equity | 45.75M | 49.33M | 9.27M | -5.55M | -16.32M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -35.95M | -1.6M | -10.11M | -9.75M | -9.58M |
Investing | -133k | N/A | N/A | N/A | N/A |
Financing | 22.18M | 778k | 7.65M | 7.38M | 6.89M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -15.69M | -47.31M | -65.2M | -35.95M | -9.58M |
Investing | -98k | -40.69M | 39.46M | -133k | N/A |
Financing | 42.42M | 67.99M | 30.42M | 22.18M | 6.89M |
Market Cap | 4.13M |
Price to Earnings Ratio | -0.28 |
Price to Sales Ratio | 0.21 |
Price to Cash Ratio | 1.61 |
Price to Book Ratio | -0.25 |
Dividend Yield | - |
Shares Outstanding | 6.86M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | -79.38% |
52 Week High | 3.40 |
52 Week Low | 0.504 |
Spread (Intraday) | 0.03 (9.82%) |
Company Name | Agile Therapeutics Inc |
Address |
1111b s governors ave dover, delaware 19904 |
Website | https://www.agiletherapeutics.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions